Santarus (SNTS)to Present Phase III Data for Rifamycin SV MMX
Posted in the Los Angeles Forum
#1 Oct 4, 2013
Mike Zaman Reporting
antarus, Inc.(NASDAQ:SNTS) today announced that new data from its Phase III clinical study with the investigational drug rifamycin SV MMX® in patients with travelers’ diarrhea will be featured in a poster presentation at IDWeek™ in San Francisco at the Moscone Center (Poster Hall C) from 12:30 p.m. to 2:00 p.m. Pacific Time on Saturday, October 5, 2013.
The poster (#1306) is titled, Randomized, Double-Blind, Placebo-Controlled Study of Rifamycin SV MMX in the Treatment of Travelers’ Diarrhea. IDWeek is the combined annual meeting of the Infectious Diseases Society of America (IDSA), the Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA), and the Pediatric Infectious Diseases Society (PIDS).
#2 Oct 4, 2013
I pulled a d!rty sanchez on several of the patients. They're mudholes were dry as the above poster stated. I am selleing all of my black tar heroin to buy SNTS stock!
Add your comments below
|The 25 Most Dangerous Cities in the U.S. Are Mo... (Nov '10)||11 min||Zeke the Pinhead||20,176|
|Diversity highlighted at L.A. Asian Pacific Fil...||3 hr||Julie Ann||1|
|Transforming Union Station from a transit hub t...||4 hr||Lucy Jane||1|
|Prince created the soundtrack for my life||5 hr||Lucy Jane||1|
|Pacific Commerce Bank and ProAm rica Bank Annou...||5 hr||Lucy Jane||1|
|Pebblebrook Hotel Trust Reports First Quarter 2...||5 hr||Lucy Jane||1|
|Meet Wilshire's newest commanding officer||5 hr||Lucy Jane||1|
Find what you want!
Search Los Angeles Forum Now
Copyright © 2016 Topix LLC